Acarbose impurity D
|
阿卡波糖雜質(zhì)D
|
|
Acarbose Impurity C
|
阿卡波糖雜質(zhì)C
|
|
Rosiglitazone Impurity 1
|
羅格列酮雜質(zhì) 1
|
1797979-55-5
|
Rosiglitazone Related Compound 2
|
羅格列酮相關(guān)化合物2
|
1924671-90-8
|
Rosiglitazone Related Compound 1
|
羅格列酮相關(guān)化合物1
|
768-38-7
|
N-Desmethyl rosiglitazone
|
N-去甲基羅格列酮
|
257892-31-2
|
Rosiglitazone-d3
|
羅格列酮-d3
|
1132641-22-5
|
Finafloxacin HCl
|
非那沙星鹽酸鹽
|
209342-41-6
|
Diazepam Impurity ZY1
|
地西泮雜質(zhì)ZY1
|
|
Diazepam Impurity 1
|
地西泮雜質(zhì)1
|
36020-94-7
|
Diazepam Impurity 2
|
地西泮雜質(zhì)2
|
102725-59-7
|
Ezetimibe Impurity 56
|
依折麥布雜質(zhì)56
|
1296129-15-1
|
Ezetimibe Impurity 9
|
依折麥布雜質(zhì)9
|
272778-12-8
|
Ezetimibe Impurity 8
|
依折麥布雜質(zhì)8
|
189028-93-1
|
Acarbose Impurity B
|
阿卡波糖雜質(zhì)B
|
|
Acarbose Impurity A
|
阿卡波糖雜質(zhì)A
|
|
rac-Carbidopa EP Impurity C
|
消旋卡比多巴EP雜質(zhì)C
|
85933-19-3
|
Cabozantinib N-Oxide
|
卡博替尼氮氧化物
|
1621681-63-7
|
Carfilzomib Impurity 55 Trifluoroacetate
|
卡非佐米雜質(zhì)55三氟乙酸鹽
|
|
Cariprazine Impurity 1
|
卡利拉嗪雜質(zhì)1
|
839712-15-1
|
Cariprazine Impurity 3
|
卡利拉嗪雜質(zhì)3
|
791778-53-5
|
Cariprazine Impurity 17
|
卡利拉嗪雜質(zhì)17
|
2327471-74-7
|
Cladribine EP Impurity G
|
克拉濱EP雜質(zhì)G
|
99-75-2
|
Ralfinamide
|
拉非酰胺
|
133865-88-0
|
Lamotrigine EP Impurity B
|
拉莫三嗪EP雜質(zhì)B
|
94213-24-8
|
Letimovir Impurity ZY1
|
來特莫韋雜質(zhì)ZY1
|
917389-29-8
|
(R)-Letermovir
|
(R)來特莫韋
|
917389-37-8
|
Refenacine Impurity ZY5
|
雷芬那辛雜質(zhì)ZY5
|
|
Refenacine Impurity ZY6
|
雷芬那辛雜質(zhì)ZY6
|
|
Refenacine Impurity ZY7
|
雷芬那辛雜質(zhì)ZY7
|
|
Rasagiline Impurity 10
|
雷沙吉蘭雜質(zhì)10
|
34698-41-4
|
Rasagiline Sulfate
|
雷沙吉蘭硫酸鹽
|
|
N-2-Propynyl Rasagiline
|
N2丙炔基雷沙吉蘭
|
1458609-07-8
|
rac-Rasagiline
|
消旋雷沙吉蘭
|
1875-50-9
|
Rasagiline Impurity 8 HCl
|
雷沙吉蘭雜質(zhì)8鹽酸鹽
|
92850-02-7
|
Rasagiline Impurity 5 Mesylate
|
雷沙吉蘭雜質(zhì)5甲磺酸鹽
|
1312077-04-5
|
Rasagiline Impurity ZY1
|
雷沙吉蘭雜質(zhì)ZY1
|
3349-60-8
|
Rasagiline Impurity 11
|
雷沙吉蘭雜質(zhì)11
|
83-33-0
|
Rasagiline Mesylate
|
雷沙吉蘭甲磺酸鹽
|
161735-79-1
|
Ruxolitinib Impurity 8
|
魯索替尼雜質(zhì)8
|
2102675-40-9
|
Ruxolitinib Impurity 9
|
魯索替尼雜質(zhì)9
|
2102675-42-1
|
Ropivacaine EP Impurity B
|
羅哌卡因EP雜質(zhì)B
|
27262-40-4
|
Ropivacaine Impurity 10
|
羅哌卡因雜質(zhì)10
|
99552-32-6
|
Chloropropiophenone
|
氯苯丙酮
|
936-59-4
|
Methocarbamol Dioxolane
|
美索巴莫二氧戊環(huán)
|
2049-21-0
|
Metomidate Hydrochloride
|
美托咪酯鹽酸鹽
|
35944-74-2
|
Mexiletine Alcohol
|
美西律醇
|
61102-09-8
|
Mexiletine Impurity ZY1
|
美西律雜質(zhì)ZY1
|
|
Mirtazapine EP Impurity D
|
米氮平EP雜質(zhì)D
|
61337-68-6
|
Mirtazapine EP Impurity D HCl
|
米氮平EP雜質(zhì)D鹽酸鹽
|
1188265-41-9
|
Mirtazapine EP Impurity E
|
米氮平EP雜質(zhì)E
|
191546-94-8
|
Milrinone Impurity 6
|
米力農(nóng)雜質(zhì)6
|
88349-61-5
|
Milrinone Impurity 8
|
米力農(nóng)雜質(zhì)8
|
80442-07-5
|
Nicergoline EP Impurity A
|
尼麥角林EP雜質(zhì)A
|
38536-28-6
|
Nicergoline EP impurity F
|
尼麥角林EP雜質(zhì)F
|
58001-19-7
|
(R,S)-Palonosetron
|
(R,S)帕洛諾司瓊
|
135755-51-0
|
Palonosetron USP Related Compound E(free base)
|
(游離)帕洛諾司瓊USP相關(guān)化合物E
|
|
Pasireotide Impurity 14
|
帕瑞肽雜質(zhì)14
|
|
Pemetrexed EP Impurity A
|
培美曲塞EP雜質(zhì)A
|
869791-42-4
|
Pemetrexed Impurity 7
|
培美曲塞雜質(zhì)7
|
1644287-27-3
|
Pemetrexed Impurity 13
|
培美曲塞雜質(zhì)13
|
193281-05-9
|
(3S,5S)-Pitavastatin Calcium Salt
|
(3S,5S)匹伐他汀鈣鹽
|
254452-92-1
|
Pemetrexed EP Impurity B+C
|
培美曲塞EP雜質(zhì)B+C
|
|
Pemetrexed EP Impurity D
|
培美曲塞EP雜質(zhì)D
|
144051-68-3
|
(3R,5R)-Pitavastatin Calcium Salt
|
(3R,5R)匹伐他汀鈣鹽
|
254452-96-5
|
(Z)-Pitavastatin Calcium Salt
|
(Z)匹伐他汀鈣鹽
|
1159588-21-2
|
(3S,5R)-Pitavastatin Calcium Salt
|
(3S,5R)匹伐他汀鈣鹽
|
254452-88-5
|
Prasugrel EP Impurity G
|
普拉格雷EP雜質(zhì)G
|
1391054-37-7
|
Tazobactam USP Related Compound A
|
他唑巴坦USP相關(guān)化合物A
|
120701-87-3
|
Sofosbuvir Impurity 3
|
索非布韋雜質(zhì)3
|
|
Entecavir
|
恩替卡韋
|
142217-69-4
|
Entecavir Impurity A
|
恩替卡韋雜質(zhì)A
|
|
Entecavir EP Impurity C
|
恩替卡韋雜質(zhì)C
|
2204369-23-1
|
Entecavir EP Impurity D HCl
|
恩替卡韋雜質(zhì)D
|
1367369-80-9
|
Remdesivir
|
瑞德西韋
|
1809249-37-3
|
Remdesivir Impurity 1
|
瑞德西韋雜質(zhì)1
|
1355049-95-4
|
Telmisartan EP Impurity E
|
替米沙坦EP雜質(zhì)E
|
884330-12-5
|
Telmisartan EP Impurity F
|
替米沙坦EP雜質(zhì)F
|
915124-86-6
|
Telmisartan Related Compound 2
|
替米沙坦相關(guān)化合物2
|
88433-09-0
|
Telmisartan Impurity 11
|
替米沙坦雜質(zhì)11
|
84859-27-8
|
Telmisartan
|
替米沙坦
|
144701-48-4
|
(racemic)Tazobactam USP Related Compound A
|
(外消旋)他唑巴坦USP相關(guān)化合物A
|
118175-11-4
|
Umeclidinium Bromide Impurity 12 Bromide
|
烏美溴銨雜質(zhì)12溴化物
|
2253743-40-5
|
Cinacalcet Impurity 40
|
西那卡塞雜質(zhì)40
|
1344557-18-1
|
Cinacalcet Impurity ZY1
|
西那卡塞雜質(zhì)ZY1
|
|
Nifuratel Impurity 1
|
硝呋太爾雜質(zhì)1
|
|
Nifuratel Impurity 5
|
硝呋太爾雜質(zhì)5
|
34143-33-4
|
Neostigmine Impurity 8 Metilsulfate
|
新斯的明雜質(zhì)8硫酸甲酯
|
39218-17-2
|
Bromfenac Impurity 5 Sodium Salt
|
溴芬酸雜質(zhì)5鈉鹽
|
1391052-54-2
|
Bromfenac Impurity 5
|
溴芬酸雜質(zhì)5
|
241825-87-6
|
9-Oxo Epinastine HCl
|
9-氧代依匹斯汀鹽酸鹽
|
141342-69-0
|
Eptifibatide Impurity 12
|
依替巴肽雜質(zhì)12
|
|
Levadopa Related Compound A
|
左旋多巴相關(guān)化合物A
|
27244-64-0
|
Telmisartan EP Impurity C
|
替米沙坦EP雜質(zhì)C
|
144702-26-1
|
Sofosbuvir
|
索非布韋
|
1190307-88-0
|
Sofosbuvir Impurity 1
|
索非布韋雜質(zhì)1
|
|
Sofosbuvir Impurity 2
|
索非布韋雜質(zhì)2
|
863329-62-8
|
Eprosartan related compound E
|
依普羅沙坦相關(guān)化合物E
|
3006-96-0
|
Eptifibatide Impurity ZY1
|
依替巴肽雜質(zhì)ZY1
|
|
Eptifibatide Impurity 11
|
依替巴肽雜質(zhì)11
|
135900-78-6
|